Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Interleukin-18/blood"'
Autor:
Ndate Fall, Rachel A. Brown, Cem Gabay, Scott W. Canna, Grant S. Schulert, Shima Yasin, Alexei A. Grom, Maggie Henderlight, Charlotte Girard-Guyonvarc'h
Publikováno v:
Rheumatology (Oxford)
Rheumatology, Vol. 59, No 2 (2020) pp. 361-366
Rheumatology, Vol. 59, No 2 (2020) pp. 361-366
Objectives Systemic juvenile idiopathic arthritis (sJIA) is a childhood arthritis with features of autoinflammation and high risk of macrophage activation syndrome (MAS). IL-18 has been shown to have key roles in sJIA and MAS. We aimed to examine IL-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79ba4d1d3f195f1dcc4a6caf87082ac7
https://doi.org/10.1093/rheumatology/kez282
https://doi.org/10.1093/rheumatology/kez282
Autor:
Daniel Peckham, Paul Whitaker, Anil Mehta, Sinisa Savic, Michael F. McDermott, T. Scambler, J. Holbrook, Christine Etherington, Ian Clifton, Heledd H. Jarosz-Griffiths, Samuel Lara-Reyna, Giulia Spoletini, C. Wong, Fabio Martinon
Publikováno v:
eLife
eLife, Vol 9 (2020)
eLife, vol. 9, pp. e54556
eLife, Vol 9 (2020)
eLife, vol. 9, pp. e54556
Previously, we showed that serum and monocytes from patients with CF exhibit an enhanced NLRP3-inflammasome signature with increased IL-18, IL-1β, caspase-1 activity and ASC speck release (Scambler et al. eLife 2019). Here we show that CFTR modulato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e56c3b19820b0ec649de1acb486b5ee6
https://eprints.whiterose.ac.uk/158253/7/elife-54556-v2.pdf
https://eprints.whiterose.ac.uk/158253/7/elife-54556-v2.pdf
Autor:
Peter Lamprecht, Thierry Schaeverbeke, Hendrik Schulze-Koops, Eugen Feist, Jürgen Rech, Bernhard Hellmich, Eduardo Schiffrin, Delphine S. Courvoisier, Jacques Morel, Thierry Martin, Eric Hachulla, Bruno Fautrel, Andrew Sleight, Cem Gabay, Ina Kötter, Mohamed Hamidou, François Spertini
Publikováno v:
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 13, pp.annrheumdis--2017--212608. ⟨10.1136/annrheumdis-2017-212608⟩
Annals of the Rheumatic Diseases, Vol. 77, No 6 (2018) pp. 840-847
Annals of the Rheumatic Diseases, 2018, 13, pp.annrheumdis--2017--212608. ⟨10.1136/annrheumdis-2017-212608⟩
Annals of the rheumatic diseases, vol. 77, no. 6, pp. 840-847
Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 13, pp.annrheumdis--2017--212608. ⟨10.1136/annrheumdis-2017-212608⟩
Annals of the Rheumatic Diseases, Vol. 77, No 6 (2018) pp. 840-847
Annals of the Rheumatic Diseases, 2018, 13, pp.annrheumdis--2017--212608. ⟨10.1136/annrheumdis-2017-212608⟩
Annals of the rheumatic diseases, vol. 77, no. 6, pp. 840-847
Objectives Adult-onset Still’s disease (AOSD) is a rare systemic autoinflammatory disease; its management is largely empirical. This is the first clinical study to determine if interleukin (IL)-18 inhibition, using the recombinant human IL-18 bindi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c65d696a1d83184a5233ce120c7211e
https://doi.org/10.1136/annrheumdis-2017-212608
https://doi.org/10.1136/annrheumdis-2017-212608